This process readily included well‐studied cancer drivers such as TP53, KRAS, NRAS, AKT1, BAP1, and PIK3CA. Apart from these known cancer‐related genes, there were several new and important mutations that might affect NPC etiology and tumorigenesis (Figure 2A). This evidence concerns the gene AKT1 and cancer.